Our models help scientists predict the results of new and currently impossible experiments to move their science forward much ...

It has been pointed out that unless South Korea overcomes the challenge of securing accurate and extensive medical data, not only will the spread of ...

CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.

SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Yatiri Bio Inc. today announced it has received a grant from the Gates ...

CN Bio expands its research services with new in silico tools to improve ADME profiling and drug discovery translation.

A new generative AI model trained on UK Biobank data can simultaneously forecast the risks and timing of developing over ...

OXFORD, England--(BUSINESS WIRE)--Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The partnership ...

CAMBRIDGE, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune ...

Rejuvenate Bio Inc. has released new preclinical efficacy data for its gene therapy, RJB-0402, in a mouse model of arrhythmogenic cardiomyopathy (ACM), an inherited disease caused by mutations in one ...

Nuvation Bio Inc (($NUVB)) announced an update on their ongoing clinical study. In a significant development for lung cancer treatment, Nuvation ...